BRIEF-Vesicor Therapeutics And Black Hawk Acquisition Corporation Enter Into A Business Combination Agreement

Reuters
29 Apr
BRIEF-Vesicor <a href="https://laohu8.com/S/LENZ">Therapeutics</a> And Black Hawk Acquisition Corporation Enter Into A Business Combination Agreement

April 28 (Reuters) - Black Hawk Acquisition Corp BKHA.O:

  • VESICOR THERAPEUTICS, INC. AND BLACK HAWK ACQUISITION CORPORATION ENTER INTO A BUSINESS COMBINATION AGREEMENT TO CREATE A BIOTECHNOLOGY COMPANY ADVANCING P53-BASED CANCER THERAPEUTICS DELIVERED VIA MICROVESICLES

  • BLACK HAWK ACQUISITION CORP - VESICOR VALUED AT PRE-MONEY EQUITY VALUE OF $70 MILLION

Source text: ID:nGNX44wRYQ

Further company coverage: BKHA.O

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10